✦ LIBER ✦
OR7-4: A phase 2, six-month dose-response study to investigate TransCon hGH, a long-acting hGH, in treatment naïve children with idiopathic growth hormone deficiency (IGHD)
✍ Scribed by Chatelain, P.; Malievsky, O.; Radziuk, K.; Elsedfy, H.; Mikhailova, E.; Beckert, M.
- Book ID
- 126758804
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 442 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1096-6374
No coin nor oath required. For personal study only.